Advertisement: RSM
Advertisement Cambridge China Centre
Mid banner advertisement: BDO
Advertisement EY mid banner
Barr Ellison Solicitors – commercial property
RealVNC mid banner careers
RealVNC mid-banner general
Advertisement: Cambridge Network
Advertisement: Bradfield Centre mid
Advertisement: Mogrify
ARM Innovation Hub
25 January, 2006 - 21:45 By Staff Reporter

London Asia buys China bio stake

London Asia, the Essex based investment and merchant banking group, has bought a controlling stake in China Biotech Healthcare Ltd for £647,000.London Asia, the Essex based investment and merchant banking group, has bought a controlling stake in China Biotech Healthcare Ltd for £647,000.

China Biotech is a Jersey incorporated holding company for Century Huanding Biomed-icine Technology, a profitable technology commercialisation company, which develops and distributes healthcare products in partnership with leading Chinese universities and research institutes.

London Asia will take a 51 per cent holding in China Biotech, which achieved pro forma profits for the year ended 30 June 2005 of £299k, a 69 per cent increase on the previous year. The investment is via the issue of 3,282,234 London Asia ordinary 5p shares at 18p a share, and the payment of US$100K (£57k) in cash.

Huanding’s core product is a unique, herbal derived bio-chromium supplement for long-term diabetes treatment. China is ranked second in the world in the incidence of diabetes and has an estimated 35 to 50 million people suffering from the disease.

Add new comment

Newsletter Subscription

Stay informed of the latest news and features